Cytomegalovirus immune reconstitution in recipients of allogeneic haematopoietic stem cell transplant research hub

Evaluation of a laboratory test called QuantiFERON Cytomegalovirus in allogeneic stem cells transplant patients to assess its ability to detect the timing when the patients' immune system can control cytomegalovirus infection, thus allowing the clinical team the discontinuation of antiviral prophylaxis

This study looks at a blood test (QuantiFERON-CMV) for people who've had a stem cell transplant. It aims to see if the test can tell doctors when a patient's immune system is strong enough to fight a virus called CMV, potentially helping to decide when to stop antiviral medicine.